Strategic fit Target large biotech and pharma labs that require high-sensitivity non-invasive liquid biopsy tools. Potential sales angles include RainDrop Digital PCR and ThunderStorm enrichment systems for oncology biomarker discovery, early detection programs, and infectious disease research.

Global reach Leverage RainDance international sales and service network and distributors to expand in regions with growing genomics investment. Partnerships with academic and research institutions can accelerate adoption of RainDrop and ThunderBolt solutions.

Upgrade opportunities Position RainDrop Plus updates as a productivity and throughput upgrade to existing RainDrop users, emphasizing faster droplet detection, automated analysis, and higher sample throughput to justify capex and service contracts.

Strategic partnerships Explore collaboration with bioscience equipment integrators and contract research organizations (CROs) that can bundle RainDance systems with downstream sequencing and analysis workflows, expanding addressable market and recurring revenue from service and training.

Funding and acquisitions Highlight RainDance heritage and technology advantage to corporate buyers and potential acquirers by showcasing strong IP, validated performance in non-invasive genomics, and a track record of growth and major research institution adoption to support discussions around collaboration or acquisition.